Literature DB >> 20043680

Urotensin-II receptor modulators as potential drugs.

Bruce E Maryanoff1, William A Kinney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20043680     DOI： 10.1021/jm901294u

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  9 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.

Authors:  Yavuz Pehlivan; Recep Dokuyucu; Tuncer Demir; Davut Sinan Kaplan; Ibrahim Koc; Mustafa Orkmez; Ibrahim Halil Turkbeyler; Ali Osman Ceribasi; Ediz Tutar; Seyithan Taysi; Bunyamin Kisacik; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

3.  Insights into the Molecular Determinants Involved in Urocontrin and Urocontrin A Action.

Authors:  Etienne Billard; David Chatenet
Journal:  ACS Med Chem Lett       Date:  2020-08-20       Impact factor: 4.345

4.  Urotensin-#receptor antagonist SB-706375 protected isolated rat heart from ischaemia-reperfusion injury by attenuating myocardial necrosis via RhoA/ROCK/RIP3 signalling pathway.

Authors:  Jing-Si Duan; Shuo Chen; Xiao-Qing Sun; Juan Du; Zhi-Wu Chen
Journal:  Inflammopharmacology       Date:  2019-06-05       Impact factor: 4.473

5.  Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.

Authors:  D Chatenet; M Létourneau; Q T Nguyen; N D Doan; J Dupuis; A Fournier
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart.

Authors:  N D Doan; T T M Nguyen; M Létourneau; K Turcotte; A Fournier; D Chatenet
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo.

Authors:  D J Behm; N V Aiyar; A R Olzinski; J J McAtee; M A Hilfiker; J W Dodson; S E Dowdell; G Z Wang; K B Goodman; C A Sehon; M R Harpel; R N Willette; M J Neeb; C A Leach; S A Douglas
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 8.  Targeting of G-protein coupled receptors in sepsis.

Authors:  Abdul Rehman; Noor Ul-Ain Baloch; John P Morrow; Pál Pacher; György Haskó
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

9.  Update on the urotensinergic system: new trends in receptor localization, activation, and drug design.

Authors:  David Chatenet; Thi-Tuyet M Nguyen; Myriam Létourneau; Alain Fournier
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-02       Impact factor: 5.555
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.